GLENDALE, Calif. --(BUSINESS WIRE)--Feb. 2, 2017-- Avery Dennison Corporation (NYSE:AVY) today announced that its board of directors has appointed Andres A. Lopez a director, effective February 1, 2017 . Lopez, 54, is the president, chief executive officer and executive director of Owens-Illinois,
Irish-based company brings new products, manufacturing capabilities in high-value healthcare materials business GLENDALE, Calif. --(BUSINESS WIRE)--May 22, 2017-- Avery Dennison Corporation (NYSE:AVY) announced today that it has acquired Finesse Medical Ltd.
1Q17 Reported EPS of $1.25 Adjusted EPS (non-GAAP) of $1.11 1Q17 Net sales increased ~6% to $1.57 billion Organic sales growth (non-GAAP) of ~4% Raised FY17 guidance midpoint for Reported EPS by $0.08 Raised FY17 guidance midpoint for Adjusted EPS (non-GAAP) by $0.18 GLENDALE, Calif.
4Q17 Reported EPS of ($0.66) , incl. impact of the U.S. tax legislation change Adjusted EPS (non-GAAP) of $1.33 4Q17 Net sales increased 11.9% to $1.74 billion Sales change ex. currency (non-GAAP) of 9.1% Organic sales change (non-GAAP) of 4.7% FY17 Reported EPS of $3.13 Adjusted EPS of $5.00 FY17
The Avery Dennison ® Monarch ® Freshmarx ® 9417+ solution is designed to make food safety compliance labeling simple and reliable MIAMISBURG, Ohio --(BUSINESS WIRE)--Oct. 25, 2016-- Avery Dennison , a Fortune 500 ® global leader in labeling and packaging materials and solutions, announced from its
2Q18 Reported EPS of $1.07 Adjusted EPS (non-GAAP) of $1.66 2Q18 Net sales increased 14.0% to $1.85 billion Sales change ex. currency (non-GAAP) of 10.0% FY18 Reported EPS guidance midpoint reduced by $0.33 , driven by ~$0.60 estimated impact of recently announced termination of U.S.
3Q16 Reported EPS of $0.98 Adjusted EPS (non-GAAP) of $1.01 3Q16 Net sales increased approx. 3 percent to $1.51 billion Organic sales growth (non-GAAP) of approx. 3 percent Repurchased 2.7 million shares (1 mil. net of dilution) and paid $106 million in dividends in the first nine months of 2016